Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Dow
Healthtrust
Queensland Health
Johnson and Johnson
McKesson
Express Scripts
Cantor Fitzgerald
Argus Health

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,635,172

« Back to Dashboard

Summary for Patent: 5,635,172
Title: Sustained release comfort formulation for glaucoma therapy
Abstract:Disclosed are nonstinging, sustained release ophthalmic formulations to control intraocular pressure in antiglaucoma therapy comprising a basic active, a cation exchange resin, and, inter alia, an acidic, mucomimetic polymer. Also disclosed are methods of treatment comprising administering such formulations topically to the eye when indicated for control and lowering of intraocular pressure.
Inventor(s): Jani; Rajni (Fort Worth, TX), Harris; Robert G. (Fort Worth, TX)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX)
Application Number:08/396,284
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 5,635,172

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,635,172

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1607495 ➤ Try a Free Trial
Australia 4575389 ➤ Try a Free Trial
Australia 621692 ➤ Try a Free Trial
Australia 688854 ➤ Try a Free Trial
Canada 2004468 ➤ Try a Free Trial
Canada 2181929 ➤ Try a Free Trial
Germany 68913979 ➤ Try a Free Trial
European Patent Office 0429732 ➤ Try a Free Trial
European Patent Office 0741563 ➤ Try a Free Trial
Finland 962976 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Accenture
Deloitte
US Army
McKinsey
Colorcon
Cipla
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot